Well, Q4 2016 *is* a matter of months (perhaps as few as eight), but maybe you mean two or three months. That would be great and I hope it turns out to be so. I'm guessing conservatively because there are often logistics behind the scenes that investors don't know about (until after the fact maybe). I think if the company planned to initiate Phase 2b/3 in 1H 2016 it would say so. Since it hasn't, I assume the trial will begin in 2H 2016. Regardless of 1H or 2H, though, I think a 2016 start to that trial is awesome and in keeping with the rapid advancement of 2-73 that we've seen over the last couple years.
Market Data 
Markets 
AI
